Sangamo Therapeutics
SGMO
#9891
Rank
S$67.54 M
Marketcap
S$0.16
Share price
-5.48%
Change (1 day)
-74.88%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: S$67.54 Million

As of May 2026 Sangamo Therapeutics has a market cap of S$67.54 Million. This makes Sangamo Therapeutics the world's 9891th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026S$67.54 M-63.21%
2025S$0.18 B-74.71%
2024S$0.72 B470.55%
2023S$0.12 B-81.55%
2022S$0.68 B-53.3%
2021S$1.47 B-49.42%
2020S$2.91 B123.13%
2019S$1.30 B-18.34%
2018S$1.60 B-13.56%
2017S$1.85 B494.69%
2016S$0.31 B-65.69%
2015S$0.90 B-34.54%
2014S$1.38 B26.71%
2013S$1.09 B180.9%
2012S$0.38 B102.06%
2011S$0.19 B-50.28%
2010S$0.38 B3.79%
2009S$0.37 B83.36%
2008S$0.20 B-73%
2007S$0.75 B112.98%
2006S$0.35 B72.9%
2005S$0.20 B-17.07%
2004S$0.24 B6.66%
2003S$0.23 B79.48%
2002S$0.12 B-69.47%
2001S$0.42 B-43.45%
2000S$0.74 B

End of Day market cap according to different sources

On May 17th, 2026 the market cap of Sangamo Therapeutics was reported to be:

S$71.46 Million
by Nasdaq info icon info icon
S$71.46 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$704.14 B 1,042,325.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$223.83 B 331,265.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$36.20 B 53,496.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
S$35.51 B 52,472.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$205.71 B 304,448.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$355.23 B 525,791.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$48.83 B 72,200.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$12.26 B 18,060.89%๐Ÿ‡บ๐Ÿ‡ธ USA